Here are the speakers of the 15th Asian Congress (SIOP Asia) of the International Society for Pediatric Oncology to be held at the Yerevan State Medical University in May of this year:
Gertjan Kaspers/Gert-Jan Kaspers
Center: Princess Máxima Center for Pediatric Oncology/ Prinses Maxima centrum, Netherlands
Position: Director Academy & Outreach of Princess Máxima Center
Topic: Acute myeloid leukemia and acute promyelocytic leukemia in Low and Middle Income Countries.
Professor Gertjan Kaspers is a pediatric oncologist who specializes in acute myeloid leukemia and acute promyelocytic leukemia. He is the director of the Academy and Outreach program at Princess Maxima Center for pediatric oncology in the Netherlands and a professor of pediatric oncology at the Vrije University Amsterdam. Professor Kaspers is committed to improving the survival chances and quality of life of children in low-middle income countries.
Petr Sedláček
Center: University Hospital Motol, 2nd Medical School, Charles University Prague
Position: Head of Hematopoietic Stem Cell Transplant Unit at Department of Pediatric Hematology and Oncology.
Topic: Allogeneic hematopoietic stem cell transplantation following reduced intensity conditioning in hypoplastic refractory cytopenia of childhood.
Prof. Sedlacek is currently Professor of Pediatrics at the Charles ́ University, Prague, Head of Hematopoietic Stem Cell Transplant Unit at the Department of Pediatric Hematology and Oncology. In the past he was a visiting physician at Hadassah University Hospital, Fred Hutchinson Cancer Research Center (Seattle, USA) and Fairview Hospital at the University of Minnesota (Minneapolis, USA).
He is a member of the Czech Society of Physicians, EBMT, ASBMT, and I-BFM.
Ching-Tien Peng MD, MPH
Center: China Medical University & Hospitals, Taichung, Taiwan
Position: Professor of China Medical University, Children's Hospital, Professor of Biotechnology, Asia University, President of Taiwan Society on Thrombosis and Hemostasis
Prof. Ching-Tien Peng is a pediatric hematologist-oncologist, who specializes in benign hematology. Among his research interests are thalassemias and hemophilias. He is the President of the Taiwan Society on Thrombosis and Hemostasis, he is a Professor of Pediatrics and Hematology/Oncology at China Medical University and Professor of Biotechnology at Asia University. He is also the former Superintendent of the Children's Hospital of China Medical University․
Ibrahim Qaddoumi, MD, MS
Center: St. Jude Children's Research Hospital, USA
Position: Associate Member of St. Jude Faculty, Director of Global Neuro-Oncology Program, Director of Jordan Program
Topic: Low grade gliomas
Dr. Ibrahim Qaddoumi is a pediatric oncologist specialized in pediatric neuro-oncology. Among his research interests are low grade gliomas, retinoblastoma, and delayed diagnosis in pediatric CNS tumors. He is one of the first specialists who applied telemedicine in neuro-oncology.
Dr. Qaddoumi is a member of St. Jude Global and director of the Global Neuro-oncology program which aims to promote the development of neuro-oncology in LMICs. Currently, he is the director of Virtual Pediatric Neuro-oncology Fellowship Program at St. Jude Global.
Rashmi Dalvi, MD, DCH
Center: Bombay Hospital Institute of Medical Sciences, India
Position: MUHS Professor, Head of Department of Pediatrics & Pediatric Hematology Oncology at the Bombay Hospital Institute of Medical Sciences.
Prof. Dalvi is a visiting consultant at NH-SRCC Children’s hospital and PHO-BMT Department of LTMG Medical College Hospital, in Mumbai.
She was a pioneer in the development and promotion of Pediatric Hematology Oncology (PHO) subspecialty in India. Prof. Dalvi has been involved in academics and clinical practice in PHO, Immunology for over 30 years. Among her special interests are lymphomas, nutrition, supportive care, registries, and histiocytic disorder.
Prof. Rashmi Dalvi is an active member of SIOP for the Pediatric Oncology in Developing Countries Committee since 1992; a founding member of the SIOP-India project, “NTP-PPO” addressing Early Diagnosis Treatment Abandonment in children with cancer. She has held various positions including Chair of the National PHO Society, India (2009-12), Chair of SIOP-PODC Committee on Education Training (2010-13), Chair-Coordinator NTP-PPO (2007-2012), LOC member for SIOP Asia 2002, Continental President for SIOP-Asia (2018-2021).
Andrea Ferrari, MD
Center: Fondazione IRCCS Istituto Nazionale dei Tumori
Position: Board member of European Soft Tissue Sarcoma Study Group (EpSSG), pediatric oncologist
Topic: Soft Tissue sarcomas in adolescents and young adults
Dr. Andrea Ferrari is pediatric oncologist specialized in pediatric sarcomas and rare tumors.
Among his research interests are soft tissue sarcomas, rare tumors and adolescents and young
adults with cancer. He is the founding member and member of the Board of the European
Pediatric Soft Tissue Sarcoma Study Group (EpSSG) and the Principal Coordinator of the EpSSG
Scientific Committee on Non-rhabdomyosarcoma soft tissue sarcomas. He is the chairman of the European Cooperative Study Group for Pediatric Rare Tumors (ExPERT), and co-founder and co-coordinator of the Italian TREP project (Rare Tumors in Pediatric Age). Dr. Ferrari developed the “Youth Project” in Milan and is the Chairman of the SIOP Europe AYA Committee.
He is the author or co-author of more than 330 papers published in international scientific journals.
Alexei A. Maschan MD, DSc
Center: Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Moscow (Russian Federation).
Position: Deputy General Director of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia, Director of the
Institute of Children Hematology, Immunology and Cell Technologies at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia.
Topic: Combined immunosuppressive therapy with or without eltrombopag in children with
acquired aplastic anemia: results of a randomized trial.
Professor Maschan became one of the first scientists who introduced hematopoietic stem cell transplantation in children and described clear indications for this type of therapy. He formed a unified approach to the diagnosis and treatment of hematological diseases in children. On the
scientific basis, professor Maschan created a new paradigm for transplantations of
hematopoietic stem cells in children, which made it possible to improve treatment results.
Frederick A. Boop, MD
Center: St. Jude Children’s Research Hospital, University of Tennessee Health Science Center.
Position: Professor and J.T. Robertson Chair, Department of Neurosurgery, University of Tennessee Health Science Center
Topic: Surgical treatment of pediatric CNS tumors
Professor Frederick Boop is the Chair of the Department of Neurosurgery, University of
Tennessee Health Science Center. For many years he was the chair of Division of Pediatric Neurosurgery at the LeBonheur Children’s Hospital. Currently, he is a consultant neurosurgeon at St. Jude Global. Prof. Boop is a member of multiple professional societies. He is involved in a multi-center clinical trial of new programmable shunt valves and in the clinical investigation of outcomes following surgery for intractable epilepsy and spasticity.
It should be reminded that the century-old Medical University will bring together the leading players in the field of pediatric oncology on May 19-21, contributing to the multiplication of national achievements.
View the registration cost and perks for each attendance category on the .